Skip to content

Benechim: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Benechim

BE 0405.952.225
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€200,996
2024 · €1.6m-€1.4m
Equity
€29.5m
2024 · €29.3m+€200,996
Cash
€3.7m
2024 · €3.4m+€253,258
Balance sheet total
€33.9m
2024 · €36.4m-€2.5m

Largest movements

2024 to 2025
Assets
  • Stocks and contracts -€2.7m

    down €2.7m (-20.1%), from €13.3m to €10.6m

  • Tangible fixed assets -€1.1m

    down €1.1m (-17.2%), from €6.5m to €5.4m

    of which Plant, machinery and equipment: -€952,074

  • Receivables within one year +€981,402

    up €981,402 (+24.3%), from €4.0m to €5.0m

    of which Other amounts receivable: +€934,035

Equity and liabilities
  • Trade debts -€1.7m

    down €1.7m (-33.8%), from €5.1m to €3.4m

  • Tax, wage and social debts -€1.1m

    down €1.1m (-58.7%), from €1.8m to €741,097

    of which Taxes: -€981,630

Income statement
  • Turnover -€5.9m

    down €5.9m (-17.0%), from €34.8m to €28.9m

  • Goods and materials -€5.7m

    down €5.7m (-32.5%), from €17.5m to €11.8m

    of which Purchases: -€6.9m

  • Taxes -€360,845

    down €360,845 (-65.0%), from €554,833 to €193,988

    of which Taxes: -€427,549

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €1.6m
Turnover -€5.9m
Other operating income -€2,978
Goods and materials +€5.7m
Services and other goods +€289,090
Staff costs +€8,217
Depreciation +€51,889
Write-downs -€254,628
Other operating charges -€42,414
Other operating items -€1.5m
Financial income +€81,164
Financial charges -€156,510
Taxes +€360,845
Result 2025 €200,996

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€961,702
Investment -€708,445
Financing €0
Cash 2024 €3.4m
Net result for the year +€200,996
Depreciation +€1.8m
Stocks and contracts +€2.7m
Receivables within one year -€981,402
Deferred charges and accrued income +€55,048
Trade debts -€1.7m
Tax, wage and social debts -€1.1m
Advances received +€99,000
Accrued charges and deferred income -€56,601
Investment in fixed assets (net) -€708,445
Cash 2025 €3.7m
Every line side by side 71 lines
Line Code 2024 2025 Change %
Total assets 20/58 €36,439,383 €33,897,102 -€2.5m -7.0%
Fixed assets 21/28 €15,506,353 €14,460,337 -€1.0m -6.7%
Intangible fixed assets 21 €0 €0 = 0.0%
Tangible fixed assets 22/27 €6,483,925 €5,368,605 -€1.1m -17.2%
Land and buildings 22 €2,768,587 €2,581,089 -€187,498 -6.8%
Plant, machinery and equipment 23 €3,683,288 €2,731,214 -€952,074 -25.8%
Furniture and vehicles 24 €32,051 €24,715 -€7,336 -22.9%
Assets under construction and advance payments 27 - €31,588 +€31,588
Financial fixed assets 28 €9,022,428 €9,091,732 +€69,304 +0.8%
Affiliated companies 280/1 €8,947,361 €8,947,361 = 0.0%
Participating interests 280 €8,947,361 €8,947,361 = 0.0%
Other financial fixed assets 284/8 €75,066 €144,371 +€69,304 +92.3%
Amounts receivable and cash guarantees 285/8 €75,066 €144,371 +€69,304 +92.3%
Current assets 29/58 €20,933,031 €19,436,764 -€1.5m -7.1%
Stocks and contracts in progress 3 €13,283,974 €10,608,097 -€2.7m -20.1%
Stocks 30/36 €13,283,974 €10,608,097 -€2.7m -20.1%
Raw materials and consumables 30/31 €3,866,223 €3,471,209 -€395,015 -10.2%
Work in progress 32 €833,653 €1,143,710 +€310,057 +37.2%
Finished goods 33 €8,584,098 €5,993,178 -€2.6m -30.2%
Amounts receivable within one year 40/41 €4,045,418 €5,026,820 +€981,402 +24.3%
Trade receivables 40 €3,807,165 €3,854,532 +€47,367 +1.2%
Other amounts receivable 41 €238,253 €1,172,288 +€934,035 +392.0%
Cash at bank and in hand 54/58 €3,447,363 €3,700,621 +€253,258 +7.3%
Deferred charges and accrued income 490/1 €156,275 €101,227 -€55,048 -35.2%
Total equity and liabilities 10/49 €36,439,383 €33,897,102 -€2.5m -7.0%
Equity 10/15 €29,286,564 €29,487,559 +€200,996 +0.7%
Contributions 10/11 €628,000 €628,000 = 0.0%
Revaluation surpluses 12 €1,265,097 €1,265,097 = 0.0%
Reserves 13 €4,171,547 €4,171,547 = 0.0%
Non-distributable reserves 130/1 €62,800 €62,800 = 0.0%
Reserves not available under the articles 1311 €62,800 €62,800 = 0.0%
Tax-exempt reserves 132 €1,983 €1,983 = 0.0%
Distributable reserves 133 €4,106,763 €4,106,763 = 0.0%
Profit (loss) carried forward 14 €23,221,921 €23,422,916 +€200,996 +0.9%
Amounts payable 17/49 €7,152,819 €4,409,542 -€2.7m -38.4%
Amounts payable within one year 42/48 €6,923,734 €4,237,057 -€2.7m -38.8%
Trade debts 44 €5,127,784 €3,396,960 -€1.7m -33.8%
Suppliers 440/4 €5,127,784 €3,396,960 -€1.7m -33.8%
Advances received on contracts in progress 46 - €99,000 +€99,000
Taxes, remuneration and social security 45 €1,795,950 €741,097 -€1.1m -58.7%
Taxes 450/3 €1,171,787 €190,157 -€981,630 -83.8%
Remuneration and social security 454/9 €624,163 €550,940 -€73,223 -11.7%
Accrued charges and deferred income 492/3 €229,086 €172,485 -€56,601 -24.7%
Operating income 70/76A €34,189,722 €26,788,915 -€7.4m -21.6%
Turnover 70 €34,831,881 €28,923,106 -€5.9m -17.0%
Change in stocks of work in progress, finished goods and contracts in progress 71 -€764,085 -€2,253,139 -€1.5m -194.9%
Other operating income 74 €121,926 €118,948 -€2,978 -2.4%
Operating charges 60/66A €32,065,432 €26,326,732 -€5.7m -17.9%
Goods for resale, raw materials and consumables 60 €17,481,055 €11,794,509 -€5.7m -32.5%
Purchases 600/8 €18,333,426 €11,403,374 -€6.9m -37.8%
Change in stocks: decrease (increase) 609 -€852,371 €391,135 +€1.2m
Services and other goods 61 €7,967,693 €7,678,604 -€289,090 -3.6%
Remuneration, social security and pensions 62 €4,758,932 €4,750,715 -€8,217 -0.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,806,350 €1,754,460 -€51,889 -2.9%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 -€223,024 €31,604 +€254,628
Other operating charges 640/8 €274,426 €316,840 +€42,414 +15.5%
Operating profit (loss) 9901 €2,124,290 €462,183 -€1.7m -78.2%
Financial income 75/76B €127,532 €208,696 +€81,164 +63.6%
Recurring financial income 75 €127,532 €208,696 +€81,164 +63.6%
Income from current assets 751 €13,327 €20,365 +€7,037 +52.8%
Other financial income 752/9 €114,204 €188,331 +€74,127 +64.9%
Financial charges 65/66B €119,385 €275,895 +€156,510 +131.1%
Recurring financial charges 65 €119,385 €275,895 +€156,510 +131.1%
Debt charges 650 €10,110 €11,399 +€1,290 +12.8%
Other financial charges 652/9 €109,275 €264,496 +€155,220 +142.0%
Profit (loss) for the period before taxes 9903 €2,132,437 €394,984 -€1.7m -81.5%
Income taxes 67/77 €554,833 €193,988 -€360,845 -65.0%
Taxes 670/3 €621,537 €193,988 -€427,549 -68.8%
Tax adjustments and reversals of tax provisions 77 €66,704 - -€66,704
Profit (loss) for the period 9904 €1,577,604 €200,996 -€1.4m -87.3%
Profit (loss) for the period to be appropriated 9905 €1,577,604 €200,996 -€1.4m -87.3%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.